Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human B cell interleukin 10

D Benjamin1, C D Park, V Sharma

  • 1Division of Hematology and Oncology, Arthur G. James Cancer Hospital and Research Institute, Columbus, Ohio 43210.

Leukemia & Lymphoma
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dose escalation with simultaneous integrated boost for un-methylated multiple glioblastoma.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology·2024
Same author

High-precision measurement of the <i>W</i> boson mass with the CDF II detector.

Science (New York, N.Y.)·2022
Same author

Search for the Exotic Meson X(5568) with the Collider Detector at Fermilab.

Physical review letters·2018
Same author

Combined Forward-Backward Asymmetry Measurements in Top-Antitop Quark Production at the Tevatron.

Physical review letters·2018
Same author

Azorella selago Hook. used to estimate glacier fluctuations and climatic history in the Kerguelen Islands over the last two centuries.

Oecologia·2017
Same author

Tevatron Combination of Single-Top-Quark Cross Sections and Determination of the Magnitude of the Cabibbo-Kobayashi-Maskawa Matrix Element V_{tb}.

Physical review letters·2015
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
Same journal

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Leukemia & lymphoma·2026
Same journal

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026
Same journal

Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.

Leukemia & lymphoma·2026
See all related articles

Interleukin 10 (IL-10), a lymphokine homologous to Epstein-Barr virus BCRF1, is highly secreted by B cells in AIDS-related lymphomas. This suggests IL-10 may drive lymphoma growth and is involved in non-Hodgkin

Area of Science:

  • Immunology
  • Virology
  • Oncology

Background:

  • Interleukin 10 (IL-10) is a lymphokine with sequence homology to Epstein-Barr virus (EBV) open reading frame BCRF1.
  • EBV-positive B cell lines from AIDS and Burkitt's lymphoma patients secrete significantly more IL-10 than other EBV-positive B cell lines.
  • EBV-negative B cell lines do not express IL-10.

Purpose of the Study:

  • To investigate the role of IL-10 in B cell lymphomas, particularly in the context of EBV and HIV-1 infections.
  • To determine the relationship between IL-10 production and B cell differentiation stages.
  • To explore the potential involvement of IL-10 and BCRF1 in the pathophysiology of non-Hodgkin's lymphomas.

Main Methods:

  • Analysis of IL-10 secretion in various EBV-positive and EBV-negative B cell lines using Northern blot, ELISA, and PCR.

Related Experiment Videos

  • Investigation of IL-10 production in B cells at different differentiation stages.
  • Experimental infection of tonsillar B cells with EBV to assess IL-10 secretion.
  • Correlation of IL-10 levels with HIV-1 infection in AIDS-related lymphomas.

    • Main Results:

    • EBV-positive B cell lines from AIDS and Burkitt's lymphoma patients exhibited high IL-10 secretion.
    • IL-10 expression was restricted to mature and pre-plasmacytic B cell stages, not detected in earlier or myeloma cells.
    • EBV infection directly induced IL-10 secretion in tonsillar B cells.
    • Elevated IL-10 in AIDS-related lymphomas suggests a role for HIV-1 in its secretion.

    Conclusions:

    • B cell IL-10 is implicated in the pathogenesis of non-Hodgkin's lymphomas.
    • IL-10 may act as an autocrine growth factor for B cell lymphomas.
    • Both IL-10 and the EBV-encoded BCRF1 protein appear to play roles in non-Hodgkin's lymphoma development.